On Monday, November 8th, 2010, Synthes USA (SUSA) announced that it had acquired Anspach Incorporated, a West Palm Beach, Florida based company known for its high speed pneumatic and electric powered tools for neuro, orthopaedic, spinal and ear, nose and throat surgery. Having visited Anspach on numerous occasions, Synthes acquired much more than state-of-the art powered tools. Anspach corporate headquarters now provides Synthes a satellite office where cadaver labs can be offered for the Southeast, Southwest and Mid-Atlantic Regions. But this is really only a small benefit of this acquisition. Today, Synthes now offers one of the most comprehensive power tool portfolios with a power tool division with close to $200 million dollars in sales.
Looks like the Almighty Stryker better start looking over its shoulder, there's a new sheriff in town and his name ain't Reggie Hammond. Is this the new Syntes (love that lisp)? In addition, they have bought some nice shoulder instruments, considering that they have been attempting to get into the shoulder market over the last few years. This organization has done a wonderful job of assimilating itself into the American culture of buying, rather than developing their own products, especially when it is cheaper to gobble up a leading company rather than develop it organically. But what does it say about R&D at Syntes? You know that new generation of engineers, love sitting in front of a computer rather than being in surgery. Will they become the next T-Rex in the industry, gobbling up anything that's worth their cash. You be the judge. TSB wants to know what our readers think.
Get in On, Bang the Gong, Get it On!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!